{"name":"Groupe Francais De Pneumo-Cancerologie","slug":"groupe-francais-de-pneumo-cancerologie","ticker":"","exchange":"","domain":"","description":"Groupe Francais De Pneumo-Cancerologie is a French organization focused on research and development in oncology, particularly in lung cancer and related diseases. The group is involved in clinical trials and the advancement of diagnostic methods and treatments.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Blood sample for liver function tests","genericName":"Blood sample for liver function tests","slug":"blood-sample-for-liver-function-tests","indication":"Monitoring liver function in clinical trials","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Blood samples for Chemistry","genericName":"Blood samples for Chemistry","slug":"blood-samples-for-chemistry","indication":"Other","status":"phase_2"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Blood samples for Hematology","genericName":"Blood samples for Hematology","slug":"blood-samples-for-hematology","indication":"Blood sample collection and analysis for hematology tests","status":"phase_2"}]}],"pipeline":[{"name":"Blood sample for liver function tests","genericName":"Blood sample for liver function tests","slug":"blood-sample-for-liver-function-tests","phase":"phase_2","mechanism":"A blood sample collection procedure used to measure hepatic enzyme levels and liver function markers for diagnostic and monitoring purposes.","indications":["Monitoring liver function in clinical trials","Detection of hepatotoxicity","Assessment of liver disease"],"catalyst":""},{"name":"Blood samples for Chemistry","genericName":"Blood samples for Chemistry","slug":"blood-samples-for-chemistry","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Blood samples for Hematology","genericName":"Blood samples for Hematology","slug":"blood-samples-for-hematology","phase":"phase_2","mechanism":"This drug is used to analyze blood samples for hematology.","indications":["Blood sample collection and analysis for hematology tests"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTFBqSjhfX2tLeXJlZWRCOU1Wc210TlRTYkhWaWx4VTVYOUJDbGZGRHB4LWVQVVRIRFNjUVV5MklDaGRtSkV3b0FGTnR4X2lwX09BSTA0dA?oc=5","date":"2013-08-20","type":"trial","source":"Nature","summary":"Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group ","headline":"Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-smal","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":3},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}